Saccharolytic bacterium

Saccharolytic bacteria are a broad functional group of microorganisms defined by their ability to metabolize carbohydrates—such as starches, dietary fibers, oligosaccharides, and other non-digestible sugars—into energy and growth substrates. Their primary metabolic process is fermentation, which yields short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate as major end products[1][5]. These SCFAs play important roles in colonic health and host metabolism. Saccharolytic activity is found across diverse bacterial taxa; predominant genera include Bacteroides (e.g., Bacteroides caccae), Bifidobacterium, Ruminococcus, Eubacterium, Lactobacillus, Clostridium among others[1][8][10]. In the human gut microbiome especially the colon—these organisms are numerically dominant among obligate anaerobes. They contribute significantly to the breakdown of complex carbohydrates that escape digestion in the upper gastrointestinal tract[1]. Saccharolytic bacteria are not a single molecular target or receptor but rather a descriptive term for any bacterium with this metabolic capability. As such they do not have a canonical gene/protein name or abbreviation; instead they represent an ecological/metabolic classification spanning multiple taxonomic families. Because "saccharolytic bacterium" refers to a functional property rather than a specific molecule or protein target commonly addressed by drugs or therapeutic interventions—and because it encompasses many species—it is not considered an individual therapeutic target like an enzyme or receptor would be. Therefore: - **This entry is incorrect as a drug discovery/therapeutic target** because it does not refer to one discrete molecule/receptor/enzyme/transporter but rather describes many different bacterial species sharing similar metabolism. - There are no direct interacting drugs targeting "saccharolytic bacterium" as such; however antibiotics can affect these populations broadly. - No specific biomarkers exist for this group collectively beyond general measures of carbohydrate fermentation products. In summary: "Saccharolytic bacterium" describes any microorganism capable of fermenting sugars/carbohydrates into SCFAs and related metabolites—a key function in human gut ecology—but does not correspond to an individual molecular drug target[1][3][5].

Other names

Saccharolytic bacteriacarbohydrate-fermenting bacteriasugar-fermenting bacteria